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Abstract
Background: The polyglutamine expansion in huntingtin (Htt) protein is a cause of Huntington's disease
(HD). Htt is an essential gene as deletion of the mouse Htt gene homolog (Hdh) is embryonic lethal in
mice. Therefore, in addition to elucidating the mechanisms responsible for polyQ-mediated pathology, it
is also important to understand the normal function of Htt protein for both basic biology and for HD.
Results: To systematically search for a mouse Htt function, we took advantage of the Hdh +/- and Hdh-
floxed mice and generated four mouse embryonic fibroblast (MEF) cells lines which contain a single copy
of the Hdh gene (Hdh-HET) and four MEF lines in which the Hdh gene was deleted (Hdh-KO). The function
of Htt in calcium (Ca2+) signaling was analyzed in Ca2+ imaging experiments with generated cell lines. We
found that the cytoplasmic Ca2+ spikes resulting from the activation of inositol 1,4,5-trisphosphate
receptor (InsP3R) and the ensuing mitochondrial Ca2+ signals were suppressed in the Hdh-KO cells when
compared to Hdh-HET cells. Furthermore, in experiments with permeabilized cells we found that the
InsP3-sensitivity of Ca2+ mobilization from endoplasmic reticulum was reduced in Hdh-KO cells. These
results indicated that Htt plays an important role in modulating InsP3R-mediated Ca2+ signaling. To further
evaluate function of Htt, we performed genome-wide transcription profiling of generated Hdh-HET and
Hdh-KO cells by microarray. Our results revealed that 106 unique transcripts were downregulated by
more than two-fold with p < 0.05 and 173 unique transcripts were upregulated at least two-fold with p <
0.05 in Hdh-KO cells when compared to Hdh-HET cells. The microarray results were confirmed by
quantitative real-time PCR for a number of affected transcripts. Several signaling pathways affected by Hdh
gene deletion were identified from annotation of the microarray results.
Conclusion: Functional analysis of generated Htt-null MEF cells revealed that Htt plays a direct role in
Ca2+ signaling by modulating InsP3R sensitivity to InsP3. The genome-wide transcriptional profiling of Htt-
null cells yielded novel and unique information about the normal function of Htt in cells, which may
contribute to our understanding and treatment of HD.
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Background
Huntington's disease (HD) is an autosomal-dominant
neurodegenerative disorder which is caused by poly-
glutamine (polyQ) expansion in the amino-terminus of
huntingtin (Htt). Htt is a soluble protein of 3,144 amino
acids that has no sequence homology with other proteins.
Except for the extreme amino-terminus, with its adjacent
polyQ region and proline-rich segments, the entire ~350-
kD protein is predicted to be composed of 36 α-helical
HEAT repeats. Increasing evidence indicates that Htt func-
tions as a molecular scaffold that is able to organize a vari-
ety of signaling complexes [1,2]. Htt is expressed
ubiquitously in humans and rodents, with the highest lev-
els found in CNS neurons and the testes [3-5]. Intracellu-
larly, Htt is associated with various organelles, including
the nucleus, endoplasmic reticulum (ER) and Golgi com-
plex [6-8]. This widespread subcellular localization does
not facilitate the definition of its function. Hdh is evolu-
tionary conserved – a single copy of the Htt gene is
expressed in all vertebrates (from fish to humans) [9]. The
Htt gene is also present in D. melanogaster genome, but
absent in the C. elegans and S. cerevisiae genomes [9]. All
vertebrate isoforms of Htt, but not Drosophila Htt, contain
an amino-terminal polyQ region.
Complete knockout of the mouse Htt gene (Hdh) causes
embryonic death before day 8.5 (E8.5, before gastrulation
and the formation of the nervous system) [10-12]. After
gastrulation, Htt becomes important for neurogenesis –
mice carrying a <50% dose of wild-type Htt display pro-
found malformations of the cortex and striatum [13].
Another study has shown that greatly reduced Htt levels
are insufficient to support normal mouse development
[14]. In addition to its function in development, Htt may
play a role in the regulation of apoptosis, control of BDNF
production, vesicular and mitochondrial transport, neu-
ronal gene transcription, and synaptic transmission
(reviewed in [9]). Despite all of these efforts and results,
the exact function of Htt in cells still remains largely
unknown.
In addition to answering an academic question concern-
ing the normal function of Htt, knowledge of its function
is important for understanding HD pathogenesis and for
the treatment of Huntington's disease (HD). Although the
HD mutation is considered to be a "gain of function"
mutation, it has been suggested that the loss of normal
Htt function might also contribute to the pathogenesis of
HD [9]. Approaches that are based on reducing mutant
Htt expression such as RNA interference [15] and the use
of intrabodies [16,17] are currently considered to be
promising strategies for HD treatment. It is likely that
these agents will cause inactivation or impair normal
function of both mutant and wild type Htt alleles. One
can envision a therapy that combines such Htt-inactivat-
ing agents with drugs that restore the function of targets
and pathways downstream from wild-type Htt. However,
because both normal Hdh function is not known and
downstream pathways have not been identified, such a
combined therapy approach is not feasible at the
moment.
To systematically search for Htt's normal function, we
used Hdh +/- [12] and Hdh-floxed mice [18] to generate
immortalized mouse embryonic fibroblasts (MEF) which
contain a single functional copy of Hdh gene (Hdh-HET)
or lack Hdh completely (Hdh-KO). We compared inositol
1,4,5-trisphosphate receptor (InsP3R)-mediated Ca2+ sig-
nals in these cells. We then performed a genome-wide
gene transcription profiling of Hdh-HET and Hdh-KO MEF
cells using microarrays to obtain novel, unique, and unbi-
ased information about the normal function of Htt in
fibroblasts, which may contribute to our understanding
and treatment of HD.
Results
Generation of Hdh-HET and Hdh-KO MEF cell lines
To generate cell lines lacking Htt expression, we employed
a conditional mutagenesis strategy based on the in vitro
recombination of an Hdh(flox) allele in cultured fibrob-
lasts that are also carrying either a wild-type (+) or null
(standard knock-out) Hdh  allele. The Hdh(flox/+) and
Hdh(flox/-) fibroblasts were obtained from embryos
derived from a cross between Hdh +/- and Hdh-floxed/
floxed mice (Fig 1). Primary fibroblasts were prepared and
plated separately from each embryo as described in Meth-
ods. After two days in culture, the primary fibroblasts
from all embryos with identical genotype (Hdh floxed/+
or  Hdh  floxed/-) were pooled together and transfected
with a linearized SV40 plasmid. Transfected cells were
then cultured for four to six weeks until immortalized Hdh
floxed/+ and Hdh floxed/- mouse embryonic fibroblasts
(MEFs) were obtained (Fig 1). To recombine the Hdh
floxed allele, immortalized Hdh floxed/+ and Hdh floxed/
- MEFs were infected with Lenti-NLS-GFP-Cre virus encod-
ing nuclear-targeted GFP-Cre fusion protein [19] (Fig 1).
Using the procedure described above, we generated four
Hdh-HET (lines 1,2,3,5) and four Hdh-KO (lines 11, 12,
16, 27) MEF cell lines. The expression of Htt in the gener-
ated MEF lines was assessed by Western blotting of whole
cell lysates using anti-Htt monoclonal antibody. Quantifi-
cation of Western blotting data verified similar levels of
Htt expression in all 4 Hdh-HET lines (data not shown).
Consistent with the genotype of the generated cells, we
detected a protein of predicted size (~350 kD) in lysates
from the Hdh-HET cells, but not in lysates from Hdh-KO
lines (Fig 2). The same samples were probed with mono-
clonal antibodies against β-actin as a loading control (Fig
2). Thus, we concluded that we successfully generated
four  Hdh-HET and four Hdh-KO MEF lines on similarBMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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Experimental procedure used to generate the Hdh-HET and Hdh-KO MEF cell lines Figure 1
Experimental procedure used to generate the Hdh-HET and Hdh-KO MEF cell lines. The flow chart schematically 
describes the experimental paradigm used to generate Hdh-HET and Hdh-KO MEF cell lines. Please see text for details.BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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genetic background. We reasoned that comparison of
resulting MEF lines may reveal clues about normal func-
tion of Htt protein in cells.
Intracellular calcium signaling in Hdh-HET and Hdh-KO 
MEF cell lines
Previous studies have implicated impaired calcium signal-
ing in the pathogenesis of HD [20-22]. The Htt directly
binds to the inositol 1,4,5-trisposphate receptor (InsP3R),
an intracellular Ca2+ release channel [23,24]. The expres-
sion of mutated Htt has been shown to affect the InsP3R
activity [23] and mitochondrial Ca2+ signals and bioener-
getics [25-30]. Since Htt and mutated Htt directly targets
both ER and mitochondrial sites, it is possible that Htt
may have some relevance for the physical and local Ca2+
coupling between ER and mitochondria [31,32]. To test
this idea and to determine a role played by Htt in intrac-
ellular Ca2+ signaling, we performed a series of cytosolic
and mitochondrial Ca2+ imaging experiments with gener-
ated MEF lines. Two Hdh-HET (HET1 and HET 5) and two
Hdh-KO MEF cell lines (KO12 and KO27) (Fig 2) were
selected for Ca2+ imaging studies.
In these experiments Hdh-HET and Hdh-KO MEF cell lines
were challenged by ATP, an agonist of InsP3 signaling
pathway in fibroblasts. Before stimulation with ATP the
incubation medium was switched to a Ca2+ free buffer to
prevent Ca2+ entry. The cytosolic [Ca2+]c and mitochon-
drial [Ca2+]m levels were monitored simultaneously as
described in Methods. We found that pre-stimulation
[Ca2+]c was higher in the Hdh-HET cells (HET1, 183 ± 11
nM (n = 42) and HET5 139 ± 9 nM (n = 33)) than that in
Western blotting analysis of Hdh-HET and Hdh-KO MEF lines Figure 2
Western blotting analysis of Hdh-HET and Hdh-KO MEF lines. The whole cell lysates from 4 Hdh-HET and 4 Hdh-KO 
MEF cel lines were probed with anti-Htt monoclonal antibody. The same samples were also probed with anti-actin monoclonal 
antibody as a loading control. The ECL was used for detection.BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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the Hdh-KO cells (KO12, 102 ± 12 nM (n = 15) and KO27,
106 ± 6 nM (n = 48), p < 0.003). Stimulation with a sub-
optimal dose of ATP (2 μM) elicited large [Ca2+]c spikes in
Hdh-HET cells, whereas only a small and slow [Ca2+]c rise
was evoked in the Hdh-KO cells (Fig 3, Δ[Ca2+]c: HET1,
374 ± 24 nM; HET5, 386 ± 40 nM; KO12, 266 ± 47 nM
and KO27, 284 ± 25 nM; p < 0.03). Many Hdh-KO cells
did not show any [Ca2+]c rise in response to 2 μM ATP (not
shown). Mobilization of the residual Ca2+ by optimal ATP
(100 μM) evoked a relatively large [Ca2+]c elevation in the
Hdh-KO cells (Fig 3). The ATP-induced [Ca2+]c spikes were
closely followed by a [Ca2+]m elevation in the Hdh-HET
cells, whereas the [Ca2+]m rise was modest in the Hdh-KO
cells (Fig 3). Thus, the ATP-induced intracellular Ca2+
mobilization was suppressed and desensitized in the Hdh-
KO cells.
Figure 3 has also showed that the [Ca2+]c signal was effec-
tively propagated to the mitochondria in the Hdh-HET
cells but less Ca2+ was transferred into the mitochondria
in the Hdh-KO cells. To determine whether this resulted
from the attenuated ER Ca2+  mobilization or from
impaired ER-mitochondrial Ca2+ coupling, the [Ca2+]m
rise was plotted against the [Ca2+]c increase for each cell.,
The relationship between [Ca2+]c elevations and the ensu-
ing [Ca2+]m signals was similar in both the Hdh-HET and
in the Hdh-KO cells (not shown). This result indicated
that the local coupling between ER and mitochondria is
maintained in the Hdh-KO cells.
The attenuated ATP-induced [Ca2+]c signal in the Hdh-KO
cells could be due to reduced InsP3 generation, due to
reduced sensitivity of InsP3R or due to depleted ER Ca2+
pool. To discriminate between these possibilities the
InsP3-induced Ca2+ mobilization was quantified in sus-
pensions of permeabilized MEF cells. The steady state
[Ca2+]c was similar in both Hdh-HET and in Hdh-KO cells
(Fig 4A, HET1, n = 12; HET5, n = 12; KO12, n = 13; KO27,
n = 10 measurements). The Ca2+ pool size for both the ER
and the ionophore-sensitive compartment was larger in
Cytoplasmic and mitochondrial Ca2+ signals in Hdh-HET and Hdh-KO cells Figure 3
Cytoplasmic and mitochondrial Ca2+ signals in Hdh-HET and Hdh-KO cells. MEF cells were transfected with mitochondrial matrix-targeted 
inverse pericam and were loaded with Fura-2/AM to monitor [Ca2+]m and [Ca2+]c, respectively. A. [Ca2+]c and [Ca2+]m signals in HET5 and KO27 cells. In 
the images, the inverse pericam fluorescence is shown in the gray scale; the blue overlay indicates the sites of the ATP-induced [Ca2+]m elevations (upper 
row of images). The Fura2 images are presented as green-red overlay where the [Ca2+]c elevations are indicated by a green to red shift (lower row). The 
graphs show the calibrated [Ca2+]c signal and the pericam fluorescence response (ΔFmito-pcam, decrease normalized to the initial fluorescence level) to the 
sequential stimulation by low (loATP, 2 μM) and high (hiATP, 100 μM) ATP in the single cells marked by the numbers. B. Mean [Ca2+]c and [Ca2+]m signals 
in Hdh-HET and Hdh-KO MEF cells. Traces show the mean of at least triplicate measurements for each cell line. The data are representative of four inde-
pendent experiments.BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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the Hdh-KO than in the control cells (Fig 4A), whereas the
uncoupler-sensitive mitochondrial compartment showed
no difference (n = 3; not shown). Sequential application
of a suboptimal and optimal InsP3 revealed lesser InsP3-
sensitivity in the Hdh-KO cells than in the HET cells (Fig
4B, 4C, p < 0.01). However, the InsP3 sensitive fraction of
the ER was approximately 75% in both control and Hdh-
HET cells (Fig 4D). Furthermore, neither the passive Ca2+
buffering nor the mitochondrial Ca2+ uptake was altered
in the cells lacking the Hdh (Fig 4E, 4F). Collectively, the
data obtained in permeabilized cells suggest that the InsP3
sensitivity of the InsP3 receptor is attenuated in the Hdh-
deficient cells, providing a mechanism to underlie the
suppression of the InsP3-linked [Ca2+]c signaling in the
Hdh-KO cells. The effect of Hdh on the InsP3 sensitivity is
likely to be mediated by direct association between Htt
and InsP3R [23,24].
Microarray analysis of transcripts expressed in Hdh-KO 
and Hdh-HET MEFs
The results described in the previous section suggested
that Htt plays a direct role in Ca2+ signaling by modulating
InsP3R function. Many studies suggested that Htt also
plays a major role in control of gene transcription [33,34].
To uncover potential gene expression changes we per-
formed genome-wide transcription profiling of Hdh-HET
and Hdh-KO MEF cells. Using the procedures described in
Methods, we isolated total RNA from Hdh-HET MEF lines
1, 2 (in duplicate), 3, and 5 (in duplicate) and from Hdh-
KO MEF lines 11, 12, 16 (in duplicate), 27 (in duplicate).
The resulting 12 samples were provided to the UT South-
western Microarray Core Facility (MCF) for genome-wide
expression profiling using Sentrix Mouse-6 Expression
Bead Chips (Illumina) (see Methods for details).
All 12 arrays produced highly reproducible and consistent
gene expression data. The microarray results have been
deposited in NCBIs Gene Expression Omnibus (GEO),
and are accessible through GEO Series accession number
GSE11139 [35]. Cluster analysis of the over-all gene
expression data from the 12 samples demonstrated that
all six Hdh-HET samples and all six Hdh-KO samples were
clustered together, forming two clearly distinct groups
(Fig 5). We also found that the duplicate samples (HET5.1
and HET5.2, HET2.1 and HET2.2, KO16.1 and KO16.2,
and KO 27.1 and KO27.2) were most similar to each other
when compared to other samples (Fig 5), as should be
expected. Thus, we concluded that we obtained a high
quality dataset of transcripts expressed in Hdh-HET and
Hdh-KO MEF lines.
In the next level of analysis, we combined all results
obtained in six arrays with the Hdh-HET samples (HET
group) and in six arrays with the Hdh-KO samples (KO
group). Using Illumina BeadStudio software, we per-
formed a statistical analysis to identify the differentially
expressed genes between the Hdh-KO and Hdh-HET
groups. We found that from 45992 probes existing on the
Mouse-6 BeadChips arrays, 14,065 probes were present
(with detection p-value < 0.01) in at least one of these two
groups. Statistical analysis (t-test) has identified 821 tran-
scripts that were significantly different between Hdh-HET
and Hdh-KO groups (p < 0.05) (Fig 6). Among these 821
targets, 455 were up-regulated in the KO group and 366
were down-regulated (Fig 6). Thus, we concluded that
inactivation of Hdh expression has a very significant effect
on the transcriptional profile of MEF cells. The average sig-
nal intensities for each probe in Hdh-HET and Hdh-KO
groups are included in the Excel format for the 821 differ-
entially expressed targets (Additional files 1 and 2).
Analysis and annotation of microarray data
In the annotation of microarray data, we focused on 279
unique genes whose expression differed by at least 2-fold
between Hdh-HET and Hdh-KO groups. From these genes
173 genes (104 of which are annotated) were up-regu-
lated and 106 genes (65 of which were annotated) were
down-regulated in Hdh-KO cells when compared to Hdh-
HET cells. In order to extract biological information from
these genes, we performed annotation of the array results
using the Ingenuity Pathway Analysis platform [36] and
the GoStat software [37]. We found that several significant
GO categories can be pulled from the data: developmental
process (35), nervous system development and function
(19), lipid metabolism (18), glucosamine metabolic
process (2), transcription regulator activity (5),
cellular_component:plasma membrane (16), regulation
of cellular process (29), endocytosis (2), mitochondrion
(3), extracellular matrix (2), cytoskeleton (5), others (33),
indicating the possible disruption of several functional
pathways in the absence of Htt (Additional files 1 and 2).
We have not observed significant changes in gene expres-
sion levels of most proteins involved in Ca2+ signaling
pathways (Additional files 1 and 2), indicating that Ca2+
signaling changes observed in our functional experiments
(Figs 2, 3, 4) are likely to be due to post-translational
effects, such as for example changes in InsP3R gating prop-
erties.
Confirmation of gene expression with real-time PCR
In order to confirm our microarray results, we performed
quantitative real-time PCR (qPCR) analysis for several of
the candidate genes. For these experiments we choose
three genes that were significantly down-regulated in Hdh-
KO MEFs (Hdh, Sox-2, Tcf2) and three genes that were sig-
nificantly up-regulated in Hdh-KO MEFs (Cart1, Esm1,
Pitx2) (Additional files 1 and 2). We observed a good cor-
relation between averaged microarray results and qPCR
data for all six genes evaluated (Table 1). Moreover, we
observed a good correlation between microarray andBMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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Ca2+ handling by Hdh-HET and Hdh-KO cells Figure 4
Ca2+ handling by Hdh-HET and Hdh-KO cells. Fluorimetric measurements of cytoplasmic Ca2+ using Fura-2 (A-D) or FuraFF (E and F) in permeabi-
lized Hdh-HET and Hdh-KO MEF cells were conducted as described in Materials and Methods. A. Steady state [Ca2+]c values and the size of the intracellular 
calcium pools in HET1, HET5, KO12 and KO27 cells. Prestimulation steady state [Ca2+]c obtained in presence of ATP 2 mM, creatine phosphate 5 mM, 
creatine phosphokinase 5 units/ml and succinate 2 mM. To obtain the size of InsP3, ER and total ionomycin-sensitive pools, 7.5 μM InsP3, 2 μM thapsigargin 
(Tg) and 10 μM ionomycin were added respectively. Mean ± SE of at least five independent experiments with multiple parallels (HET1: n = 12; HET5; n = 
12; KO12, n = 13; KO27, n = 10). B. Analog traces showing the [Ca2+]c responses to suboptimal (250 nM) and optimal InsP3 (7.5 μM) and Tg for HET1, 
HET5, KO12 and KO27 cells. Changes were normalized to the size of the ER Ca2+ pool. C. Suboptimal InsP3 (250 nM)-induced [Ca2+]c increase normalized 
to total InsP3-sensitive (7.5 μM) pool. D. Maximal InsP3 (7.5 μM)-induced [Ca2+]c increase normalized to total Tg-sensitive (2 μM) ER pool. E. passive Ca2+ 
buffering assessed as the [Ca2+]c increase evoked by the addition of 10 μM CaCl2 in Tg and Ruthenium Red (3 μM)- pretreated MEF cells. F. Mitochondrial 
Ca2+ uptake caused by the addition of 40 μM CaCl2. Rate of uptake was calculated for initial 30 seconds after the challenge during which the rate was lin-
ear. Correction was made for the Ruthenium Red insensitive component. Data values show mean ± standard error of at least three independent experi-
ments with multiple parallels. * indicates statistically significantly different p values (p < 0.03).BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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qPCR data for results obtained with cDNA samples from
individual Hdh-HET and Hdh-KO MEF cell lines (Fig 7).
Comparison with gene expression profiling of Hdh-null ES 
cells
When our paper was in preparation, another group inde-
pendently reported genome-wide expression profiling of
Hdh-null embryonic stem (ES) cells [38]. It is of interest
to compare our findings with Hdh-KO MEF cells with
results obtained for Hdh-null ES cells. Strehlow at al
(2007) reported that expression of 16 known transcripts
was significantly affected in Hdh-null ES cells when com-
pared to wild type ES cells. The affected transcripts were
divided into several classes of interest: protein degrada-
tion (5), extracellular matrix (4), cell division (4), and
patterning/development (3) [38]. To compare these data
with our results, we attempted to locate the genes high-
lighted by the study by Strehlow at al (2007) among the
genes which expression differs at p < 0.05 between Hdh-
KO and Hdh-HET MEF cells in our experiments. We deter-
mined that two of the three genes in the patterning/devel-
opment category (Otx2 and Pem) do not present in MEF
cell lines, Leftb/Lefty is present in MEF cell lines, but did
not show a significant difference between HET and KO
MEFs. All five genes in the protein degradation category
are present in MEF cell lines but did not show significant
difference in our experiments. We found that Adam23 is
not present in MEF cell lines. B3galt6, col4a1 and clo4a2
are present in MEF cells, but did not show significant dif-
ference. We further found that one out of four genes in cell
division category (Ccdc5) is also significantly affected in
our experiments. Ccdc5 is up-regulated in both Hdh-null
ES cells and in Hdh-KO MEF cells. Plk1 is also strongly
upregulated (8.7-fold) in Hdh-null ES cells [38] but did
not show significant difference in Hdh-KO MEF cells in
Cluster analysis of microarray data Figure 5
Cluster analysis of microarray data. Using the Illumina 
BeadStudio 1.5 software package, each of 12 arrays was 
treated as an independent experiment and cluster analysis 
was performed on the microarray hybridization results.
Altered gene expression between Hdh-HET and Hdh-KO  groups Figure 6
Altered gene expression between Hdh-HET and Hdh-KO groups. Cluster 
analysis of the 821 differentially expressed genes between Hdh-HET and Hdh-KO (p 
< 0.05). The genes were selected by comparing 6 HET samples with 6 KO samples 
using t-test with computing false discovery rate. The genes with p value <0.05 were 
selected and Hierarchical cluster analysis were performed using Cluster and 
TreeView http://rana.lbl.gov/EisenSoftware.htm. Each column represents a sample 
and each row represents a gene. The colorgram depicts high (red) and low (green) 
relative levels of gene expression in each sample.BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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our experiments. Aurkc is not present in MEF cells, while
Pttg1 is present but did not show significant difference.
Strehlow at al (2007) induced neuronal differentiation of
Hdh-null ES cells by application of retinoic acid and per-
formed microarray analysis of the in vitro differentiated
neurons at 6, 8, and 10 days post-differentiation [38]. The
expression of transcripts in the number of categories was
different between Hdh-null and wild type in vitro differen-
tiated neurons [38]. Changes in only a few genes have
been consistently observed in the two studies (Table 2).
Correlation between microarray and qPCR results Figure 7
Correlation between microarray and qPCR results. The results of the microarray and qPCR analyses are compared for 
3 genes downregulated (Hdh, Tcf2, Sox2) and 3 genes upregulated (Cart1, Esm1, Pitx2) in Hdh-KO cells. The microarray and 
qPCR results are shown for RNA extracted from 6 Hdh-KO samples (blue) and 6 Hdh-HET samples (red).BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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Discussion
Despite the importance of understanding the normal
function of Htt for both basic biology and for HD, its
function remains largely unknown [9,34]. The generation
of Hdh-null MEF cell lines described in our study provides
a new and unbiased approach to search for novel Htt
functions.
The Htt directly binds to the InsP3R, an intracellular Ca2+
release channel [23,24]. The expression of mutated Htt
has been shown to affect the InsP3R activity [23] and
mitochondrial Ca2+  signals and bioenergetics [25-30].
Thus, in the first series of experiments we evaluated
InsP3R-mediated Ca2+ cytosolic and mitochondrial Ca2+
signals in Hdh-null MEF cells. As a result of these experi-
ments we found that InsP3R sensitivity to stimulation by
InsP3 was reduced in the absence of Hdh (Figs 3 and 4).
We further found that Htt appears to be dispensable for
ER-mitochondrial Ca2+ coupling (data not shown). Thus
the altered InsP3R-induced cytoplasmic and mitochon-
drial calcium signaling in the Hdh-null MEF cells may
result from the lack of Hdh by itself and does not neces-
sarily require a secondary change in gene regulation.
Table 1: Comparison of average microarray and qPCR results for 6 selected genes. 3 genes downregulated in Hdh-KO cells are shown 
in blue, 3 genes upregulated in Hdh-KO cells are shown in red. The average signals obatined in Microarray and qPCR experiments are 
shown for each gene. Also shown are primers used for qPCR experiments and the fold change calculated from microarry and qPCR 
data by dividing average Hdh-KO signal to average Hdh-HET signal.
Gene GeneBank Acc # Microrray Q-PCR
HET KO Fold Primers (FP/RP) HET KO Fold
Hdh NM_010414 303.7 -0.9 DOWN CGTGAGCATCTGCCAACATT
CACACCGAGGATCAGGAGAGT
404.3 2.0 -202.2
Sox-2 NM_011443 233.7 -5.6 DOWN GATGCACAACTCGGAGATCAG
GCTTCTCGGTCTCGGACAA
16615.9 18.4 -903.0
Tcf2 NM_009330 255.6 7.3 -35.0 CACCTGACAGTAAAATGCAGATCA
GAGTGTGTGCTGTGGATATTCGT
4513.7 2.6 -1736.0
Cart1 NM_172553 -9.3 286.9 UP CCCTGAGAACGGAGCTCACT
TTGGCCCTTCGATTTTGAA
12.5 45701.8 3656.1
Esm1 NM_023612 -35.6 498.6 UP GCGAGGAGGATGATTTTGGT
GCATTCCATCCCGAAGGT
19.7 2966.9 150.6
Pitx2 NM_011098 124.8 1811.8 14.5 CCGAGTCCGGGTTTGG
TTGCGTTCCCGCTTTCTC
21.3 368.2 17.3
Table 2: Comparison of gene expression changes in Hdh-KO MEF and differentiated Hdh-null ES cells. The genes are classified into 
functional categories (groups) based on GO classification as explained by Strehlow at al (2007). The number of genes affected in 
differentiated Hdh-null ES cells is shown. The number of these genes present among the genes affected in our experiments with Hdh-
KO MEF cells is also shown. The official gene symbols, accession numbers, Diff scores and fold changes are shown for all overlapping 
genes. The positive Diff score corresponds to the genes upregulated in Hdh-KO MEG cells, the negative Diff score corresponds to the 
genes downregulated in Hdh-KO MEF cells. The genes which expression is affected in the opposite direction when Hdh-null ES and 
Hdh-KO MEF data are compared are shown in italic.
Gene groups Gene # HMG
paper
overlap in
SupTable 1
Overlap gene 
symbol
Accession Diff_Score change fold
extracellur space 99 1 ilvbl NM_173751.3 0.037888 2.037322394
extracellular matrix/components 
conferring tensile strength/cell adhesion
38 2 Emp3 (Ymp) NM_010129.1 85.9198 2.395867383
recepto binding/hormone activity 27 0 Epb4.1l3 NM_013813.1 23.5427 1.63780359
lysosome activity/protein degradation 17 0
enzyme inhibitor activity 15 0
growth, proliferation and differentiation 15 1 Emp3 (Ymp) NM_010129.1 85.9198 2.395867383
apoptosis 10 1 Txnl1 NM_016792.2 0.003063 2.178257007
axonogenesis 10 0
synaptic activity 14 0
wnt signaling 6 0
metal ion transport 8 1 Crip1 NM_007763 0.049374 5.609568813
transport 4 0
retinol/retinal/retinoid/isoprenoid binding 5 0BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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Interestingly, a large number of Ca2+-related genes, such
as CACNA2D3 (calcium channel, voltage-dependent,
alpha2/delta subunit 3), ITPR1 (inositol 1,4,5-trisphos-
phate receptor 1), HOMER1 (homer homolog 1), ATP2A2
(ATPase, Ca2+ transporting, cardiac muscle, slow twitch
2), DRD2 (dopamine receptor 2), PRKCB1 (protein
kinase C beta 1), PDE1B (phosphodiesterase 1B, Ca2+-cal-
modulin dependent), ATP2B2 (ATPase, Ca2+ transporting,
plasma membrane 2), CAMK2B (calcium/calmodulin-
dependent protein kinase II, beta), PLCB1 (phospholi-
pase C, beta 1), RGS4 (regulator of G-protein signaling 4),
and CAMK2A (calcium/calmodulin-dependent protein
kinase II alpha), have been recently reported to be consist-
ently and significantly downregulated in a striatal region
of symptomatic human HD patients and aging HD mouse
models [39]. These results are in agreement with the "Ca2+
hypothesis of HD" [22] and with a direct role of Htt in
intracellular Ca2+ signaling supported by our experiments.
Many studies suggested that Htt also plays a major role in
control of gene transcription [33,34]. To search for
changes in gene transcription resulting from deletion of
Htt gene, we performed a genome-wide comparison of
transcription profiles in MEF cells expressing a single copy
of Hdh (Hdh-HET cells) and in MEF cells which lack Hdh
expression (Hdh-KO cells). To minimize sources of varia-
bility, the Hdh-HET and Hdh-KO MEF cells were generated
in parallel experiments and on identical genetic back-
ground. From our annotation analysis, we found that a
large group of affected genes play a role in embryonic
development (Additional file 1). This result was not unex-
pected because Htt is essential for embryonic develop-
ment, and complete inactivation of Htt expression in
knock-out mice causes early embryonic lethality [10-12].
The functions of these genes may provide additional clues
about the mechanism responsible for embryonic lethality
in Hdh knockout mice, for example there are some similar
phenotypic manifestations between Hdh  nullizygous
embryos and knockout mutants lacking fibroblast growth
factor receptor1(fgfr1) [12]. Interestingly, we found fgfrl1
message is downregulated approximately 2-fold in Hdh-
KO MEF cells when compared to Hdh-HET cells (Addi-
tional files 1 and 2).
After gastrulation, Htt is important for neurogenesis –
mice carrying a <50% dose of wild-type Htt display pro-
found malformations of the cortex and striatum [13]. The
neuronal inactivation of Htt during mid- to late gestation,
for example, leads to neurological abnormalities and pro-
gressive degeneration (apoptotic cells in the hippocam-
pus, cortex and striatum, and a lack of axons) [18]. Our
analysis revealed a number of genes involved in nervous
system development and function which were affected in
Hdh-KO MEF cell lines (Additional file 1), and this list
should also provide useful information to guide further
studies of Htt's normal function in the nervous system.
For example, Sox-2 expression was absent from Hdh-KO
MEFs. Sox (Sry-related HMG box) genes encode transcrip-
tion factors regulating crucial developmental decisions in
different systems. Sox2 is expressed in, and is essential for,
totipotent inner cell mass stem cells and other early
multipotent cell lineages, and its ablation causes early
embryonic lethality [40]. In many different species, Sox2
is a marker of the nervous system from the beginning of
its development, it maintains a stem-cell like state and
actively inhibits neuronal differentiation, Sox2 deficiency
causes neurodegeneration and impaired neurogenesis in
the adult mouse brain. Does the absence of Sox-2 play
some role in the early embryonic lethality and neurode-
generation in Hdh  knock-out mice and conditional
knock-out mice respectively? Further studies are required
to answer these questions. Sox-11 is another sox family
gene which changes dramatically in Hdh-KO MEF cell
lines (increases about 10-fold, see Additional files 1 and
2). The widespread expression of sox-11 in both the cen-
tral and peripheral nervous system suggests that sox-11
plays a general role in neuronal development, and its
changes in Hdh-KO cells merit further investigation.
Another group of genes whose expression was signifi-
cantly affected in Hdh-KO MEF cells are the genes related
to lipid metabolism. It has been reported in another
microarray analysis using clonal striata-derived cells, that
genes involved in lipid metabolism were affected after
expressing different N-terminal 548-amino-acid Htt frag-
ments [41]. Moreover, recent biochemical data indicated
that Htt binds to caveolin and plays a direct role in choles-
terol metabolism [42]. All these data suggested that Htt
plays an important role in lipid metabolism, which may
be affected by HD mutation. Indeed, RXRG (Retinoic acid
receptor RXR-gamma) and RBP4 (retinol binding protein
4) are consistently downregulated in a striatal region of
symptomatic human HD patients and aging HD mouse
models [39].
From our analysis we also found calcium channel voltage-
dependent alpha2/delta subunit 1 (Cacna2d1) was down-
regulated about 2 fold (Additional files 1 and 2), interest-
ingly the same CACNA2D1 protein has been recently
identified as novel Htt-binding partner in unbiased mass-
spectroscopy screen [24]. A closely related alpha2/delta
subunit 3 (Cacna2d3) was reported on the 3rd place on the
list of the genes which are consistently and significantly
downregulated in a striatal region of symptomatic human
HD patients and aging HD mouse models [39]. As dis-
cussed above, these results indicate that Htt may play a
role in regulation of Ca2+ channel activity and Ca2+ signal-
ing in cells, consistent with Ca2+  hypothesis of HD
[22,43].BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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Conclusion
In conclusion, we generated four Hdh-HET and four Hdh-
KO MEF cell lines and performed functional analysis of
these cells by Ca2+ imaging methods and genome-wide
transcription profiling of these cell lines using a microar-
ray approach. Our results indicated that Htt plays a direct
role in intracellular Ca2+ signaling by directly modulating
InsP3R function in cells. The results of microarray analysis
provided a novel and unique information resource for
exploring normal function of Htt in cells. The microarray
results have been deposited in NCBIs Gene Expression
Omnibus (GEO), and are accessible through GEO Series
accession number GSE11139 [35]. The Hdh-KO cell lines
will also serve as a useful tool for future follow-up experi-
ments aimed at elucidating Htt functions in vivo.
Methods
Generation of Hdh-HET and Hdh-KO MEF cell lines
Generation and characterization of the Hdh +/- and Hdh-
floxed mice have been described previously [12,18]. E13.5
embryos obtained from a cross between the Hdh-floxed
and Hdh +/- mice were first eviscerated and decapitated,
and then the carcasses were finely minced using scissors.
The tissue obtained from each embryo was digested with
0.25% Trypsin-EDTA at 37°C for 10 min, washed once
with 10% FBS in DMEM, and the cell suspensions from
each embryo were plated separately in 10% FBS-DMEM
culture medium in order to obtain cultures of primary
fibroblasts. Following plating of the cells, the genotype of
each embryo was determined by PCR [12,18]. After two
days in culture, the primary fibroblasts from each geno-
type (Hdh  floxed/+ and Hdh  floxed/-) were pooled
together. The pooled cells were then plated on six-well tis-
sue culture plates, grown to 60–80% confluence and
transfected with SV40-Large T-antigen plasmid in
pcDNA3-Zeo vector (linearized with PvuI) using the
Fugene-6 lipofection reagent (Roche). Transfected cells
were cultured for four-six weeks until immortalized Hdh
floxed/+ and Hdh floxed/- mouse embryonic fibroblasts
(MEFs) were obtained. Hdh floxed/+ and Hdh floxed/-
immortalized MEFs were then infected with Lenti-NLS-
GFP-Cre virus [19] encoding a nuclear-targeted GFP-Cre
fusion protein. Expression of NLS-GFP-Cre in infected
cells catalyzed recombination at the Hdh(flox) loxP sites
leading to excision of the promoter and exon 1 sequences
of Hdh(flox) allele [18]. Following infection with Lenti-
NLS-GFP-Cre, the Hdh floxed/+ and Hdh floxed/- MEFs
were plated in 10% FBS-DMEM culture medium in 96
well plates at an average density of one cell/well for clonal
selection. Successful recombination with NLS-GFP-Cre
converts the Hdh floxed/+ MEFs to Hdh +/- (Hdh-HET)
MEFs and the Hdh  floxed/- MEFs to Hdh-/-(Hdh-KO)
MEFs. After four weeks in culture, several potential Hdh-
HET and Hdh-KO MEF lines were selected, expanded and
analyzed by Western blotting with monoclonal antibod-
ies against Hdh (Chemicon MAB2166, 1:500) and mono-
clonal antibodies against actin (Chemicon MAB1501,
1:2000).
Cytosolic and mitochondrial Ca2+ imaging
For measurements of mitochondrial matrix [Ca2+]
([Ca2+]m), the cells were transfected with a mitochondrial
matrix targeted inverse pericam construct [44] by electro-
poration 48–72 h prior to the imaging experiment. Before
use, the cells were preincubated in an extracellular
medium (2% BSA/ECM) consisting of 121 mM NaCl, 5
mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM
KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 10 mM glucose
and 2% bovine serum albumin (BSA), pH 7.4. To monitor
[Ca2+]c cells were loaded with 2.5 μM Fura2/AM for 20–30
min in the presence of 200 μM sulfinpyrazone and
0.003% (w/v) pluronic acid at room temperature. Before
start of the measurement the buffer was replaced by a Ca2+
free 0.25%BSA/ECM ([Ca2+] <1 μM).
Coverslips were mounted on the thermo stated stage
(35°C) of an Olympus IX70 inverted microscope fitted
with a 40× (UApo, NA 1.35) oil immersion objective. Flu-
orescence images were collected using a cooled CCD cam-
era (Pluto, Pixelvision). Excitation was rapidly switched
among 340 and 380 nm for fura2 and 495 nm for pericam
and a 510 nm longpass dichroic mirror and a 520 nm
longpass emission filter were used.
For evaluation of cytoplasmic [Ca2+] ([Ca2+]c), Fura2 fluo-
rescence was calculated for the total area of individual
cells. [Ca2+]c was calibrated in terms of nM using in vitro
dye calibration. For evaluation of [Ca2+]m the pericam-mt
signal was masked. Recordings obtained from all trans-
fected cells on the field (2–10 cells) were averaged for
comparison in each experiment. Experiments were carried
out with at least four different cell preparations. Signifi-
cance of differences from the relevant controls was calcu-
lated by ANOVA.
Measurements of cytosolic Ca2+ in permeabilized cells
The cells (2 mg protein/1.5 ml) were permeabilized in an
intracellular medium (KCl 120 mM, NaCl 10 mM,
KH2PO4 1 mM, Tris-HEPES 20 mM, and antipain, leupep-
tin and pepstatin 1 μg/ml each at pH 7.2) supplemented
with 40 μg/ml digitonin and with fura2/FA (1.5–3 μM) or
furaFF/FA (0.5 μM) and TMRE 2 μM in a stirred thermo
stated cuvette at 35°C. All the measurements were carried
out in the presence of succinate 2 mM, 2 mM MgATP and
ATP regenerating system composed of 5 mM phosphocre-
atine, 5 U/ml creatine kinase. Fura2/FA or FuraFF/FA was
added to monitor [Ca2+] in the intracellular medium that
exchanges readily with the cytosolic space and so
[Ca2+]fura2 was abbreviated as [Ca2+]c. Fluorescence was
monitored in a fluorometer (Delta-RAM, PTI) using 340BMC Neuroscience 2008, 9:38 http://www.biomedcentral.com/1471-2202/9/38
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nm, 380 nm excitation and 500 nm emission for fura2FF
and 540 nm excitation and 580 nm emission for TMRE.
Calibration of the fura fluorescence was carried out at the
end of each measurement as described previously [45].
Experiments were with at least five different cell prepara-
tions in multiple parallels. Significance of differences
from the relevant controls was calculated by ANOVA.
Microarray analysis
Total RNA was isolated from fibroblast cultures using the
TRIZOL reagent according to manufacturer's instructions
(Invitrogen). Briefly, the MEF cells were grown to 60–80%
confluence in T25 tissue culture flask, the culture medium
was aspired and 1 ml of TRIZOL reagent was added to
each flask. The cells were incubated with TRIZOL at room
temperature for 5 min. The resulting lysates were collected
from each flask, mixed with 0.2 ml of chloroform and
centrifuged at 12,000 × g for 15 min at 4°C. The superna-
tants were collected, mixed with an equal volume of 70%
ethanol at room temperature and immediately transferred
to RNAeasy mini spin columns for RNA purification
according to the manufacturer's (Qiagen) instructions.
The final RNA samples were eluted from the RNeasy mini
spin columns in 30 μl of DEPC-treated water. Using the
procedures described above, we isolated total RNA from
Hdh-HET MEF lines 1, 2 (in duplicate), 3, and 5 (in dupli-
cate), and from Hdh-KO MEF lines 11, 12, 16 (in dupli-
cate), 27 (in duplicate). The resulting 12 samples were
submitted to the UT Southwestern Microarray Core Facil-
ity for microarray analysis. Biotinylated cRNA was pre-
pared using the Illumina RNA Amplification Kit (Ambion,
Inc., Austin, TX) according to the manufacturer's direc-
tions starting with ~200 ng total RNA. Samples were puri-
fied using the RNeasy kit (Qiagen, Valencia, CA).
Hybridization to the Sentrix Mouse-6 Expression Bead-
Chip (Illumina, Inc., San Diego, CA), washing and scan-
ning were performed according to the Illumina
BeadStation 500× manual (revision C). Two BeadChips
were used, each one containing 6 arrays. For each chip,
three HET and three KO samples were analyzed to mini-
mize the effects of chip-to-chip variability. Arrays were
scanned with an Illumina Bead array Reader confocal
scanner and the data was analyzed using Illumina's Bead-
Studio software(Version 3). The raw data was background
subtracted and normalized using "cubic spline" method
in the software. The detection p values were computed
using a dynamically constructed normal model based on
the intensities of 700 negative controls. For differential
analysis, the six arrays in HET group were compared with
the six arrays in KO group using t-test with computing
false discovery rate algorithm. The genes with p value
<0.05 were considered differentially expressed and subject
for further analysis.
Quantitative Real Time PCR
Quantitative real time (qRT)-PCR was performed using an
Applied Biosystems Prism 7900HT sequence detection
system using SYBR green chemistry. Briefly, total RNA was
treated with DNase I (RNase-free, Roche Molecular Bio-
chemicals), and reverse-transcribed with random hexam-
ers using SuperScript II reverse transcriptase (Invitrogen)
to generate cDNA as previously described [46]. Primers
were designed using Primer Express Software (Perk-
inElmer Life Sciences) and validated by analysis of tem-
plate titration and dissociation curves. Each qRT-PCR
contained (final volume of 10 μl) 25 ng of reverse-tran-
scribed RNA, each primer at 150 nM, and 5 μl of 2× SYBR
Green PCR Master Mix (Applied Biosystems), and each
sample was analyzed in triplicate. Results were evaluated
by the comparative CT method (User Bulletin No. 2, Perk-
inElmer Life Sciences) using cyclophilin as the invariant
control gene.
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Additional file 1
Supplementary Table 1. The list of annotated genes significantly 
affected in Hdh-KO MEF cells. The genes are classified into significant 
GO categories (classes) as explained in the text. The official gene symbol 
and protein name are shown. Also shown is average intensity of microar-
ray signal for Hdh-HET and Hdh-KO samples and the calculated Diff 
score and p-values. Negative Diff scores correspond to genes underex-
pressed in Hdh-KO cells, positive Diff Scores correspond to genes overex-
pressed in Hdh-KO cells. The fold change is calculated by dividing 
average Hdh-HET and Hdh-KO signals. The transcripts which are not 
detected in Hdh-HET samples are shown as "up", the samples not 
detected in Hdh-KO samples are shown as "down". The Genebank acces-
sion numbers are also shown.
Click here for file
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